Literature DB >> 20508339

Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.

Praveen Sharma1, Barjesh Chander Sharma, Shiv Kumar Sarin.   

Abstract

BACKGROUND: Abnormal psychometric tests are common in cirrhotic patients without overt encephalopathy. It may seriously impair the patient's daily functioning and quality of life. Prevalence of abnormal psychometric tests after the clinical recovery of overt encephalopathy has not been studied.
MATERIALS AND METHODS: Consecutive 80 patients (age, 44.5+/-9.8 yr; M: F 66:14) with hepatic encephalopathy (HE) who recovered and met inclusion criteria were evaluated for abnormal psychometric tests ( > 2 SD) and critical flicker frequency (CFF < 38 Hz). All patients underwent number connection tests-A and B, figure connection tests -A and B (if illiterate), digit symbol test, object assembly test, CFF and arterial ammonia after one month of clinical recovery of HE.
RESULTS: Prevalence of abnormal psychometric tests (> 2SD) was seen in 58 (72.5%) patients. [33 (66%) of 50 patients on lactulose and 25 (83%) of 30 patients not on lactulose, P = 0.12]. Arterial ammonia was significantly higher in patients with abnormal psychometric tests compared to patients without it (86.3+/-22.2 vs 50.4+/-11.5 mmol/l, P = 0.01). CFF was < 38 Hz in 50 patients (62.5%). Patients with > or =2 abnormal psychometric tests had CFF significantly lower than with normal psychometric tests (35.6+/-2.3 vs 40.7+/-2.4 Hz, P = 0.001). CFF sensitivity and specificity in diagnosing > or =2 abnormal psychometric tests was 82 and 83% respectively. CFF was significantly correlated with psychometric tests [NCT-A (-0.672, P = 0.001) and B (-0.743, P = 0.001), digit symbol test (-0.533, P = 0.001), object assembly test (-0.659, P =0.001) and arterial ammonia level (-0.385, P = 0.02)].
CONCLUSION: About 73% of patients who recovered from HE had abnormal psychometric tests ( > 2SD). CFF is a simple reliable tool to find out the presence of abnormal tests.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20508339     DOI: 10.4103/0028-3886.63797

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  2 in total

Review 1.  Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Authors:  Lise Lotte Gluud; Hendrik Vilstrup; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2016-05-06

2.  Brain Gray Matter Alterations in Hepatic Encephalopathy: A Voxel-Based Meta-Analysis of Whole-Brain Studies.

Authors:  Licheng Zhu; Weihua Zhang; Lei Chen; Yanqiao Ren; Yanyan Cao; Tao Sun; Bo Sun; Jia Liu; Jing Wang; Chuansheng Zheng
Journal:  Front Hum Neurosci       Date:  2022-04-18       Impact factor: 3.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.